Akebia Therapeutics Inc (AKBA)
1.40
+0.01
(+0.72%)
USD |
NASDAQ |
May 08, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price: 1.40 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2024 | 1.51 | 1.56 | 1.38 | 1.39 | 3.968M |
| May 06, 2024 | 1.41 | 1.50 | 1.40 | 1.49 | 2.336M |
| May 03, 2024 | 1.34 | 1.42 | 1.32 | 1.37 | 3.117M |
| May 02, 2024 | 1.26 | 1.31 | 1.215 | 1.30 | 2.500M |
| May 01, 2024 | 1.25 | 1.30 | 1.24 | 1.24 | 3.111M |
| Apr 30, 2024 | 1.31 | 1.315 | 1.23 | 1.26 | 4.654M |
| Apr 29, 2024 | 1.34 | 1.38 | 1.31 | 1.32 | 1.974M |
| Apr 26, 2024 | 1.32 | 1.35 | 1.29 | 1.34 | 2.476M |
| Apr 25, 2024 | 1.35 | 1.35 | 1.31 | 1.33 | 2.561M |
| Apr 24, 2024 | 1.37 | 1.40 | 1.35 | 1.37 | 1.536M |
| Apr 23, 2024 | 1.38 | 1.41 | 1.35 | 1.37 | 2.109M |
| Apr 22, 2024 | 1.37 | 1.40 | 1.34 | 1.36 | 2.006M |
| Apr 19, 2024 | 1.35 | 1.38 | 1.31 | 1.36 | 2.956M |
| Apr 18, 2024 | 1.37 | 1.435 | 1.33 | 1.39 | 2.563M |
| Apr 17, 2024 | 1.40 | 1.42 | 1.36 | 1.39 | 2.944M |
| Apr 16, 2024 | 1.38 | 1.425 | 1.32 | 1.40 | 4.129M |
| Apr 15, 2024 | 1.42 | 1.45 | 1.39 | 1.39 | 3.898M |
| Apr 12, 2024 | 1.52 | 1.54 | 1.42 | 1.46 | 4.106M |
| Apr 11, 2024 | 1.55 | 1.55 | 1.47 | 1.53 | 3.155M |
| Apr 10, 2024 | 1.58 | 1.62 | 1.52 | 1.56 | 5.435M |
| Apr 09, 2024 | 1.50 | 1.56 | 1.47 | 1.54 | 3.604M |
| Apr 08, 2024 | 1.48 | 1.54 | 1.42 | 1.53 | 3.752M |
| Apr 05, 2024 | 1.51 | 1.56 | 1.48 | 1.49 | 3.657M |
| Apr 04, 2024 | 1.47 | 1.60 | 1.46 | 1.51 | 6.194M |
| Apr 03, 2024 | 1.59 | 1.59 | 1.43 | 1.49 | 8.637M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.25
Minimum
Nov 29 2022
13.58
Maximum
Jun 30 2020
3.192
Average
2.54
Median
Sep 23 2020
Price Benchmarks
| Ocugen Inc | 1.72 |
| Aquestive Therapeutics Inc | 3.085 |
| SELLAS Life Sciences Group Inc | 1.28 |
| Protagonist Therapeutics Inc | 27.09 |
| Stoke Therapeutics Inc | 11.61 |
Price Related Metrics
| PS Ratio | 1.348 |
| Earnings Yield | -19.77% |
| Market Cap | 293.43M |